Abstract
HPLC-DAD screening for new metabolites [1] from Streptomyces sp. TÜ 6075 revealed two series of compounds composed of five colorless and seven yellow fractions. For structure elucidation, ES-FTICR-MS, chiral GC-MS, Edman sequencing, and NMR spectroscopy were used. The isolated compounds, termed arylomycins, represent the first example of lipopeptides containing biaryl-bridged amino acids. The majority of the arylomycins exhibit antimicrobial activity against Gram-positive bacteria.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Fiedler, H.-P. Nat. Prod. Lett. 2, 119 (1993).
Vaisar, T., Urban, J. J. Mass Spectrom. 33, 505 (1998).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Schmid, D.G. et al. (2001). Biaryl-Bridged Lipopeptides from Streptomyces sp. TÜ 6075. In: Lebl, M., Houghten, R.A. (eds) Peptides: The Wave of the Future. American Peptide Symposia, vol 7. Springer, Dordrecht. https://doi.org/10.1007/978-94-010-0464-0_359
Download citation
DOI: https://doi.org/10.1007/978-94-010-0464-0_359
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-3905-5
Online ISBN: 978-94-010-0464-0
eBook Packages: Springer Book Archive